Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Breast Cancer Research and Treatment|April 8, 2022
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysisAdi Pomerantz, Daliah Tsoref, Ahuva Grubstein, et al.
Brain, Behavior, and Immunity|May 26, 2018
Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptomeRita Haldar, Lee Shaashua, Hagar Lavon, et al.
Clinical Imaging|April 12, 2023
Predictors of poor outcome following liver biopsy for the investigation of new hepatic space occupying lesion/sRachel Gingold-Belfer, Nadav Shinhar, Gil N Bachar, et al.
Gerontology|March 22, 2022
Association of Anemia with Dementia and Cognitive Decline among Community-Dwelling ElderlyAvraham Weiss, Yichayaou Beloosesky, Rachel Gingold-Belfer, et al.
Oncotarget|April 18, 2018
Premature ovarian aging in <i>BRCA</i> carriers: a prototype of systemic precocious aging?Irit Ben-Aharon, Mattan Levi, David Margel, et al.
The Israel Medical Association Journal : IMAJ|May 5, 2017
A Dedicated Follow-Up Clinic for BRCA Mutation CarriersRinat Yerushalmi, Shulamith Rizel, Dalia Zoref, et al.
Brain, Behavior, and Immunity|February 12, 2024
Peri-operative individually tailored psychological intervention in breast cancer patients improves psychological indices and molecular biomarkers of metastasis in excised tumorsTsipi Hanalis-Miller, Itay Ricon-Becker, Nahida Sakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized TrialLee Shaashua, Maytal Shabat-Simon, Rita Haldar, et al.
Plos One|November 19, 2010
Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)Linh T Nguyen, Pei Hua Yen, Jessica Nie, et al.
Frontiers in Pharmacology|May 6, 2026
Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trialsNahida Sakis, Liat Sorski, Eden Asraf, et al.
Pageof 8